GSK Spies Pfizer Challenge With $2.1bn Vaccine Company Acquisition
First Vaccine M&A Deal For Departing Barron
GSK has spotted an opportunity to challenge Pfizer’s blockbuster Prevnar franchise, but the potential of Affinivax’s platform has yet to be proven.
